800
Participants
Start Date
October 31, 2012
Primary Completion Date
May 31, 2016
Study Completion Date
May 31, 2016
TRx0237 200 mg/day
TRx0237 100 mg tablets will be administered twice daily.
Placebo
Placebo tablets will be administered twice daily. The active placebo tablets include 4 mg of TRx0237 as a urinary and fecal colorant to maintain blinding; hence the placebo group will receive a total of 8 mg/day of TRx0237.
University Hospital Brussels Department of Neurology, Brussels
GasthuisZusters Antwerpen Sint-Augustinus, Wilrijk
Alzheimer Center Southwest Netherlands, Erasmus MC, Rotterdam
Jessa Hospital, Hasselt
Regional Hospital Sint-Trudo, Sint-Truiden
Discipline of Psychiatry, University of Queensland, Herston
University Hospital Gent Department of Neurology, Ghent
University Hospital Centre Zagreb, Department of Neurology, Zagreb
Columbia University Taub Institute, New York
University Psychiatric Hospital Vrapče, Zagreb
MedicalPsych Care, PLLC, Elmsford
Research Foundation for Mental Hygiene, Inc., Orangeburg
University Medicine Berlin - Charité, CBF, Neurology, Berlin
Neurological Associates of Albany, P. C., Albany
Memory Clinic, ECRC, Berlin
Clinical Neurology Department of Neuroscience (DINOGMI) - University of Genoa, Genova
Klinik und Poliklinik für Psychiatrie und Psychotherapie Zentrum für Nervenheilkunde - Universitätsklinikum Rostock, Rostock
The Clinical Trial Center, LLC, Jenkintown
Clinical Research Services Turku (CRST), Turku
CBH Health, LLC, Rockville
IRCCS San Giovanni di Dio - Fatebenefratelli, Brescia
Clinical Trials of America, Inc, Winston-Salem
Wake Research Associates, Raleigh
Hospital Universitario La Paz, Madrid
Neurozentrum Achim Dr. med. Andreas Mahler, Achim
Neurostudies.net, Decatur
Atlanta Center for Medical Research, Atlanta
Hôpital La Grave, Toulouse
Compass Research, LLC - North Clinic, The Villages
Compass Research, LLC, Orlando
MD Clinical, Hallandale
Premiere Research Institute (Palm Beach Neurology), West Palm Beach
Brain Matters Research, Delray Beach
Alzheimer's Research and Treatment Center, Lake Worth
JEM Research, Atlantis
Axiom Clinical Research of Florida, Tampa
USF Health Byrd Alzheimer's Institute, Tampa
Bradenton Research Center, Bradenton
The Roskamp Institute, Inc., Sarasota
Meridien Research, Brooksville
Neurology Clinic, P.C., Cordova
Clinical Neuroscience Solutions CNS Healthcare, Memphis
Olive Branch Family Medical, Olive Branch
Neurological Research Center - Hattiesburg Clinic, Hattiesburg
Neurobehavorial Clinical Research, Canton
Quest Research Institute, Farmington Hills
Ruan Neurology Clinic and Research Center, Des Moines
Independent Psychiatric Consultants, Waukesha
Alexian Brothers Neurosciences Institute, Elk Grove
A.O.U. Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi, Ancona
Millennium Psychiatric Associates, Creve Coeur
Fondazione Universita 'G. D'Annunzio di Chieti, Chieti Scalo
Hôpitaux Civils de Colmar, Colmar
Hôpital de Charpennes, Villeurbanne
University of Eastern Finland, Brain Research Unit Mediteknia, Kuopio
Oklahoma Clinical Research Center, Oklahoma City
FutureSearch Trials of Dallas, LP, Dallas
Senior Adults Specialty Research, Inc., Austin
Mile High Research Center, Denver
PRA Health Sciences, Salt Lake City
Xenoscience, Inc / 21st Century Neurology, Phoenix
NoesisPharma Clinical Trials, Phoenix
Albuquerque Neuroscience, Albuquerque
Neurological Research Institute, Santa Monica
CITrials, Bellflower
Collaborative Neuroscience Network, Long Beach
Neuro-Therapeutics, Inc., Pasadena
Schuster Medical Research Institute, Sherman Oaks
Synergy East, Lemon Grove
Pacific Research Network, San Diego
Anderson Clinical Research, Redlands
ATP Clinical Research, Inc., Costa Mesa
Feldman, Robert MD, Laguna Hills
Southern California Research, LLC, Fountain Valley
San Francisco Clinical Research Center, San Francisco
Institute for Neurodegenerative Disorders, New Haven
Coastal Connecticut Research, LLC, New London
Research Center for Clinical Studies, Inc, Norwalk
Memory Enhancement Centers of America, Inc, Eatontown
Advanced Memory Research Institute of NJ PC, Toms River
RI Hospital, Providence
University of British Columbia Hospital, Clinic for Alzheimer Disease and Related Disorders, Vancouver
Parkwood Institute, London
Toronto Memory Program, Toronto
Jewish General Hospital, Montreal
Arzeneimittelforschung Leipzig GmbH, Leipzig
Azienda Ospedaliera Universitaria Sant'Andrea di Roma - Unita' di Neurologia, Roma
Fundacio ACE, Barcelona
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Universitari Mútua de Terrassa, Terrassa
Grampian NHS, Royal Cornhill Hospital, Aberdeen
Sussex Partnership NHS Foundation Trust, Cognitive Treatment and Research Unit, Crowborough
Re:Cogniton Health, London
Memory Assessment and Research Centre (MARC), Southampton
Kingshill Research Centre, Victoria Hospital, Swindon
TauRx Therapeutics Ltd
INDUSTRY